SS-31 and Mitochondrial Health
Your cells' energy factories decline with age — and SS-31 is one of the only compounds shown to protect them at the structural level. Here's the science, the evidence, and what it means.
This guide summarizes published research on SS-31 (elamipretide) and mitochondrial biology. It is educational only and not a substitute for advice from a qualified healthcare professional. Sources are listed at the end.
If aging has a single root cause that researchers keep returning to, it's the gradual breakdown of mitochondria — the tiny structures inside your cells that produce nearly all of your energy. When mitochondria falter, everything that depends on energy suffers: your heart, your muscles, your brain, your overall vitality. SS-31 is one of the most scientifically interesting compounds in this space because, unlike most "mitochondrial support" products, it doesn't just supply raw materials — it physically protects the machinery itself.
This guide explains how mitochondria work, what goes wrong with age, and exactly how SS-31 fits in — grounded in the actual published research, including the human clinical trials that set it apart from most longevity compounds.
Mitochondria 101: Your Cellular Power Plants
Inside almost every cell in your body are hundreds to thousands of mitochondria. Their job is to take the food you eat and the oxygen you breathe and convert them into ATP — the molecule your cells use as energy currency. Practically everything your body does, from a heartbeat to a thought, runs on ATP that mitochondria produce.
The energy production happens along the inner mitochondrial membrane, which is folded into structures called cristae. Embedded in these folds is the electron transport chain — a series of protein complexes that pass electrons down a line, ultimately generating ATP. The more intact and well-organized these structures are, the more efficiently the cell makes energy.
A key player here is a phospholipid called cardiolipin. Cardiolipin is found almost exclusively in the inner mitochondrial membrane, where it makes up around a fifth of the membrane and acts like structural scaffolding — it holds the electron transport chain components together and keeps the cristae properly shaped. When cardiolipin is healthy, energy production runs smoothly. When it's damaged, the whole system starts to fail. Remember cardiolipin, because it's the key to understanding SS-31.
What Goes Wrong With Age
Mitochondrial decline is considered one of the central "hallmarks of aging," and it follows a predictable, self-reinforcing pattern. Understanding this cycle makes it clear why SS-31's approach is so targeted.
Cardiolipin gets damaged
Over time, cardiolipin in the inner membrane becomes oxidized (damaged by reactive molecules). Since cardiolipin holds the energy machinery together, this is where the trouble starts.
Cristae structure breaks down
With damaged cardiolipin, the carefully folded cristae start to fragment and lose their shape. The electron transport chain components are no longer held in their efficient arrangement.
ATP production drops, damaging molecules rise
The disorganized chain makes less ATP (energy) while leaking more reactive oxygen species — the very molecules that caused the cardiolipin damage in the first place.
A vicious cycle sets in
More reactive molecules cause more cardiolipin damage, which causes more dysfunction, which produces more reactive molecules. This self-accelerating loop is a core driver of age-related decline in energy-hungry tissues.
The tissues that suffer first are the ones that need the most energy: the heart, skeletal muscle, the brain, and the kidneys. This is why mitochondrial decline shows up as fatigue, reduced exercise capacity, muscle weakness (sarcopenia), and is implicated in heart failure and neurodegeneration. Breaking this cycle is exactly what SS-31 was designed to do.
What SS-31 Is
SS-31 — also known as elamipretide, and previously by the names MTP-131 and Bendavia — is a synthetic tetrapeptide, meaning it's a very small chain of just four amino acids (with the sequence D-Arg-Dmt-Lys-Phe-NH₂). It was developed by researchers Hazel Szeto and Daniel Schiller, which is where the "SS" in its name comes from, at Weill Cornell Medical College.
What makes its structure clever is an alternating pattern of aromatic and basic amino acids that gives it two special properties: it can penetrate cells without needing a transporter, and once inside, it's drawn specifically to the inner mitochondrial membrane. In other words, SS-31 was purpose-built to go straight to the exact place where age-related energy decline begins — and it concentrates there at remarkably high levels relative to the rest of the cell.
How SS-31 Works
SS-31's mechanism comes down to one elegant action: it binds and stabilizes cardiolipin — the structural scaffolding molecule we covered earlier. By protecting cardiolipin, it addresses the root of the mitochondrial decline cycle rather than just the symptoms. Here's what that protection accomplishes:
Stabilizes Cristae Structure
By binding cardiolipin, SS-31 helps the inner membrane folds keep their proper shape — preserving the organized environment that efficient energy production depends on.
Optimizes Energy Production
With the electron transport chain held in its proper arrangement, electrons flow efficiently and ATP output is restored toward healthier levels.
Reduces Reactive Oxygen at the Source
A well-organized chain leaks far fewer reactive oxygen species. SS-31 reduces this damaging output at its origin, rather than mopping it up afterward.
Breaks the Vicious Cycle
By cutting reactive-molecule production while restoring function, SS-31 interrupts the self-reinforcing loop that drives mitochondrial decline.
Why It's Different From Ordinary Antioxidants
This is the distinction that makes SS-31 genuinely novel, and it's worth understanding clearly.
Conventional antioxidants — vitamin C, vitamin E, most supplements marketed for "oxidative stress" — work by scavenging reactive oxygen molecules after they've already been produced and released into the cell. It's a cleanup approach, and it's spread thin across the whole cell.
SS-31 works differently in two important ways. First, it concentrates specifically in the mitochondria, right where the most damaging reactive molecules are generated — not diluted across the entire cell. Second, and more importantly, it works upstream: by keeping the electron transport chain properly organized, it prevents excessive reactive oxygen from being produced in the first place. Stopping a leak at its source is fundamentally more effective than constantly mopping up the floor.
A useful way to think about it
If mitochondrial damage is a leaking pipe, ordinary antioxidants are towels on the floor — they soak up what's already spilled. SS-31 is more like a wrench that tightens the joint where the leak originates. It's a structural fix at the source, not symptom management. This is why it's described as a "mitochondria-targeted" compound rather than a general antioxidant.
What the Research Shows
Here's what sets SS-31 apart from most longevity compounds: it has genuine human clinical trial data. The majority of peptides discussed in this space rest mostly on animal studies, but SS-31 has been through multiple Phase 2 and Phase 3 trials in real patients. This depth of human research is rare in the field.
Aging Muscle & Energy (Preclinical)
Some of the most compelling longevity research comes from aging studies in mice. In a study published in Aging Cell (Campbell et al., 2019), eight weeks of SS-31 treatment reversed the age-related decline in maximum mitochondrial ATP production in aged mice, restored redox balance, and improved skeletal muscle function and exercise endurance — moving aged muscle measurably back toward a younger profile. Earlier work (Siegel et al., 2013) showed that even a single SS-31 treatment could rapidly improve mitochondrial energetics in aged muscle.
Cardiac Function (Preclinical)
A study published in eLife (2020) demonstrated that restoring mitochondrial function with SS-31 late in life reversed age-related cardiac dysfunction in old mice — a striking finding given how difficult age-related heart decline is to reverse.
Human Clinical Trials
SS-31 has been studied in humans across several conditions where mitochondrial dysfunction is central:
- Primary mitochondrial myopathy: In the TAZPOWER and related trials, SS-31 improved functional measures like the six-minute walk distance in patients with mitochondrial disease.
- Heart failure: Multiple trials (including Phase 2 work) have studied SS-31 in heart failure, with research showing improvements in measures of cardiac function and exercise capacity.
- Barth syndrome: A rare genetic mitochondrial disorder; SS-31 received Breakthrough Therapy Designation from the FDA for this condition, reflecting the strength of early evidence.
- Other areas: Age-related macular degeneration and kidney injury have also been studied.
An honest note on the clinical story
SS-31's trial history isn't a simple straight line of successes. Some earlier trials (around 2019–2020) missed their primary endpoints, which raised real questions at the time. The more recent understanding is that SS-31 works best as a precision therapy — most effective in patients with confirmed mitochondrial dysfunction, rather than as a broad treatment for everyone with a given diagnosis. This is a genuinely promising compound with real human data, but it's still an area of active research, not settled science. We'd rather you have the accurate, nuanced picture than an oversimplified one.
Areas of Research Interest
Based on the published research, SS-31 is most studied and discussed in the following contexts. These reflect where the science points — not guaranteed outcomes.
Cellular Energy & Fatigue
Because it restores ATP production efficiency, SS-31 is of interest to people dealing with low energy tied to mitochondrial decline, including age-related fatigue.
Age-Related Muscle Decline
The aging-muscle research makes SS-31 relevant to sarcopenia (age-related muscle loss), exercise capacity, and recovery in older adults.
Cardiovascular Health
The heart is one of the most energy-hungry organs, and SS-31's most clinically advanced work has been in cardiac contexts.
Cognitive & Neurological
The brain depends heavily on mitochondrial energy, making SS-31 a subject of research interest for neuroprotection and cognitive aging.
General Longevity
As a direct intervention on a core hallmark of aging, SS-31 features in longevity protocols aimed at supporting cellular energy with age.
Recovery Support
Because cellular repair is energy-intensive, SS-31 is sometimes used to support recovery, particularly when energy supply seems to be a limiting factor.
Dosing & Administration
The ranges below reflect what's cited in research and protocol literature. They are general informational references, not medical recommendations — any dosing decision should involve a qualified healthcare professional.
| Parameter | Commonly Cited |
|---|---|
| Typical research dose | Often in the range of a few mg up to ~10 mg daily (subcutaneous) |
| Route | Subcutaneous injection (the common research route); IV used in clinical trials |
| Half-life | ~4 hours (subcutaneous), supporting once-daily dosing |
| Timing | Consistent daily timing; steady state reached within days |
| Cycling | Often cycled (e.g., several weeks on, then a break), though protocols vary |
Reconstitution
Our SS-31 is supplied as a 10 mg lyophilized vial, reconstituted with bacteriostatic water before use. For step-by-step preparation and injection technique, see our how to reconstitute peptides and dosing and injection basics guides. As with any peptide, starting conservatively and assessing your response is the sensible approach.
A note on the membrane-potential detail
One interesting nuance from the research: SS-31 is drawn into mitochondria partly by their membrane potential, which means the most severely damaged mitochondria (with the lowest potential) may take up slightly less of it. In published trials this hasn't been a significant practical limitation, but it's part of why SS-31 appears to work best supporting mitochondria that are declining rather than completely failed.
Stacking for Mitochondrial Health
SS-31 is often combined with other compounds that support mitochondria through different mechanisms — which is the smart way to stack, since they complement rather than overlap. Think of it as supporting the same goal from several angles.
| Combined With | What It Adds |
|---|---|
| NAD+ | Provides the raw material (fuel) for energy production, while SS-31 protects the machinery that uses it. A classic complementary pairing. |
| MOTS-c | Drives the creation of new mitochondria (biogenesis), while SS-31 protects existing ones. Building more and protecting what you have. |
| CoQ10 (supplement) | Helps carry electrons through the transport chain; SS-31 keeps the chain itself structurally intact. |
The recurring theme: SS-31 is the structural protector. Other compounds supply fuel (NAD+), build new mitochondria (MOTS-c), or assist the chain (CoQ10). Combining mechanisms is how serious longevity protocols approach mitochondrial health. Our best anti-aging peptides guide covers how these fit into a broader strategy. If you're new to peptides, though, run one alone first to understand your response before stacking.
Safety & Considerations
SS-31 has a favorable safety profile across its clinical trials, which is one benefit of its unusually deep human research record.
Reported Side Effects
- Injection site reactions (redness, mild irritation) — the most commonly reported, as with most injectables
- Headache — reported, usually mild
- Mild gastrointestinal discomfort — occasional
Across trials, serious adverse events have been uncommon, and a notable feature is that SS-31 doesn't appear to cause receptor desensitization the way some compounds do — it works on a structural target rather than a receptor that can be "worn out."
What We Don't Fully Know
- Long-term safety in healthy aging adults (most trial data is in specific patient populations)
- Optimal dosing for general longevity use, as opposed to specific medical conditions
- Interactions with various medications
Who should be cautious
As with all peptides, SS-31 should be avoided by pregnant or breastfeeding women (no safety data), and anyone with a serious medical condition or taking prescription medications should consult a qualified healthcare professional before use. People with diagnosed mitochondrial or cardiac disease in particular should only use SS-31 under medical supervision, not on their own.
Storage
Like all peptides, SS-31 should be stored properly — dry powder kept cold, and the reconstituted solution refrigerated and never frozen. In a tropical climate this matters even more; see our guide to storing peptides in tropical climates.
Common Questions
What does SS-31 actually do?
SS-31 protects your mitochondria — your cells' energy factories — at the structural level. It binds and stabilizes cardiolipin, a molecule that holds the energy-production machinery together in the inner mitochondrial membrane. By doing this, it helps restore efficient energy (ATP) production and reduces the damaging reactive molecules that mitochondria leak when they're declining. In short, it helps your cellular power plants run more like they did when they were younger.
How is SS-31 different from a regular antioxidant?
Regular antioxidants (like vitamin C or E) scavenge damaging molecules after they've already been produced, spread across the whole cell. SS-31 concentrates specifically in the mitochondria and works upstream — by keeping the energy machinery properly organized, it prevents excessive damaging molecules from being produced in the first place. It's the difference between mopping up a spill and fixing the leak at its source.
Does SS-31 have real human research, or just animal studies?
It has genuine human clinical trial data — multiple Phase 2 and Phase 3 trials across conditions including mitochondrial myopathy, heart failure, and Barth syndrome (for which it received FDA Breakthrough Therapy Designation). This depth of human research is rare among longevity peptides. That said, the clinical story is nuanced: some earlier trials missed their goals, and the current understanding is that SS-31 works best in people with confirmed mitochondrial dysfunction rather than as a broad treatment.
Who might be most interested in SS-31?
People focused on cellular energy and longevity, older adults dealing with age-related fatigue or muscle decline, and those who've researched mitochondrial health specifically. It's also of interest to people whose energy levels haven't responded to more basic approaches, since it targets a fundamental mechanism. As always, it's best used thoughtfully and ideally with input from a knowledgeable healthcare professional.
Can I stack SS-31 with NAD+ or MOTS-c?
Yes — these are popular and logical combinations because they support mitochondria through different mechanisms. NAD+ supplies the raw material for energy production, MOTS-c helps build new mitochondria, and SS-31 protects the existing machinery. They complement rather than overlap. If you're new to peptides, establish how SS-31 affects you on its own before combining it with others.
How long until I notice anything?
SS-31 works gradually since it's restoring cellular function over time rather than producing an acute effect. Steady state in the body is reached within days, but meaningful changes in energy or capacity typically build over weeks of consistent use. It's not an instant stimulant — it's a structural support that works by improving how your mitochondria function over time.
Is SS-31 safe?
SS-31 has shown a favorable safety profile across its clinical trials, with the most common side effects being mild injection site reactions and occasional headache. Serious adverse events have been uncommon. That said, long-term data in healthy aging adults is still limited, and anyone with a medical condition, taking medications, or who is pregnant or breastfeeding should consult a healthcare professional first. Our common side effects guide covers the broader picture.
Is SS-31 legal in Costa Rica?
SS-31 is sold as a research compound in Costa Rica, the same framework used in most countries with active peptide markets. It is sold for laboratory and research purposes. Buying locally avoids the heat exposure that international shipping puts delicate peptides through. See our FAQ page for more.
Interested in SS-31 for mitochondrial support?
If you'd like to understand more about SS-31 or how it fits into a longevity approach, reach out. We answer every message personally — no pressure, no upsell.
Contact Us on WhatsAppImportant disclaimer: The information in this guide is general educational content only. It is not medical advice, a prescription, or a personalized recommendation. SS-31 (elamipretide) is being studied in clinical trials but, in its research-grade form, is not approved by the FDA, EMA, or Costa Rica's Ministerio de Salud as a finished pharmaceutical drug for general human use, and is sold as a research compound intended for laboratory and scientific study. Much of the longevity and aging evidence is preclinical; findings in animal models do not guarantee the same results in humans. Always consult a qualified healthcare professional before beginning any peptide protocol, especially if you have a medical condition or take medications. Products sold by Peptides Costa Rica are intended for laboratory and research purposes only.
- Aging Cell (Campbell et al., 2019): "SS-31 reverses age-related decrements in skeletal muscle mitochondrial function and exercise tolerance."
- Aging Cell (Siegel et al., 2013): "Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice."
- eLife (2020): "Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice."
- PNAS: "Mitochondrial protein interaction landscape of SS-31."
- Cells (Allen et al., 2021): "The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae in Barth syndrome fibroblasts."
- JACC: Heart Failure (Daubert et al., 2017): "Elamipretide improves functional performance in patients with heart failure."
- ScienceDirect: "Contemporary insights into elamipretide's mitochondrial mechanism of action and therapeutic effects."
- Szeto, H.H.: Foundational research on mitochondria-targeted Szeto-Schiller peptides, Weill Cornell Medical College.
- Cell (López-Otín et al.): "The Hallmarks of Aging" — mitochondrial dysfunction in aging.
